|
Registro Completo |
|
Biblioteca(s): |
Embrapa Caprinos e Ovinos. |
|
Data corrente: |
30/03/2000 |
|
Data da última atualização: |
25/07/2023 |
|
Autoria: |
MENZIES, P. I.; MUCKLE, C. A.; BROGDEN, K. A.; ROBINSON, L. |
|
Título: |
A field trial to evaluate a whole cell vaccine for the prevention of Caseous lymphadenitis in sheep and goat flocks. |
|
Ano de publicação: |
1991 |
|
Fonte/Imprenta: |
Canadian Journal of Veterinary Research, v. 55, n. 4, p. 362-366, Oct. 1991. |
|
Idioma: |
Inglês |
|
Conteúdo: |
Abstract: A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis (CLA) in sheep and goats was performed in one goat herd and one sheep flock over a period of three years. In goats, there was a nonstatistically significant trend for fewer cases of CLA in the vaccinated animals compared to the controls. In sheep, from six months to 36 months postinitial vaccination, the proportion of vaccinated sheep that developed CLA was significantly less (p less than 0.05) than in the control sheep. The antibody titers to Corynebacterium pseudotuberculosis as detected by microagglutination assay were significantly different (p less than 0.0001) at all times except at the initial vaccination. Swellings occurred at the vaccination site at an incidence level of 29.6% in goats and 34.1% in sheep. The vaccine appeared to be efficacious in reducing the proportion of sheep that developed CLA when challenged naturally in a field situation. |
|
Palavras-Chave: |
Experimento a campo. |
|
Thesagro: |
Linfadenite Caseosa; Vacina. |
|
Thesaurus Nal: |
Caseous lymphadenitis; Disease prevention; Goat diseases; Goats; Sheep diseases; Vaccination; Vaccines. |
|
Categoria do assunto: |
H Saúde e Patologia |
|
Marc: |
LEADER 01800naa a2200277 a 4500
001 1524108
005 2023-07-25
008 1991 bl uuuu u00u1 u #d
100 1 $aMENZIES, P. I.
245 $aA field trial to evaluate a whole cell vaccine for the prevention of Caseous lymphadenitis in sheep and goat flocks.$h[electronic resource]
260 $c1991
520 $aAbstract: A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis (CLA) in sheep and goats was performed in one goat herd and one sheep flock over a period of three years. In goats, there was a nonstatistically significant trend for fewer cases of CLA in the vaccinated animals compared to the controls. In sheep, from six months to 36 months postinitial vaccination, the proportion of vaccinated sheep that developed CLA was significantly less (p less than 0.05) than in the control sheep. The antibody titers to Corynebacterium pseudotuberculosis as detected by microagglutination assay were significantly different (p less than 0.0001) at all times except at the initial vaccination. Swellings occurred at the vaccination site at an incidence level of 29.6% in goats and 34.1% in sheep. The vaccine appeared to be efficacious in reducing the proportion of sheep that developed CLA when challenged naturally in a field situation.
650 $aCaseous lymphadenitis
650 $aDisease prevention
650 $aGoat diseases
650 $aGoats
650 $aSheep diseases
650 $aVaccination
650 $aVaccines
650 $aLinfadenite Caseosa
650 $aVacina
653 $aExperimento a campo
700 1 $aMUCKLE, C. A.
700 1 $aBROGDEN, K. A.
700 1 $aROBINSON, L.
773 $tCanadian Journal of Veterinary Research$gv. 55, n. 4, p. 362-366, Oct. 1991.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Caprinos e Ovinos (CNPC) |
|
